Expression of the inhibitory B7 family molecule VISTA in human colorectal carcinoma tumors
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of the inhibitory B7 family molecule VISTA in human colorectal carcinoma tumors
Authors
Keywords
VISTA, Immune checkpoint, PD-L1, Tumor immunity, Immunotherapy
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-20
DOI
10.1007/s00262-018-2227-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
- (2017) Vikram R. Juneja et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients
- (2017) Hojabr Kakavand et al. MODERN PATHOLOGY
- New B7 Family Checkpoints in Human Cancers
- (2017) Ling Ni et al. MOLECULAR CANCER THERAPEUTICS
- VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer
- (2017) Jianjun Gao et al. NATURE MEDICINE
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- First Tissue-Agnostic Drug Approval Issued
- (2017) Cancer Discovery
- Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer
- (2017) Allison A. Aka et al. Expert Review of Clinical Pharmacology
- The novel negative checkpoint regulator VISTA is expressed in gastric carcinoma and associated with PD-L1/PD-1: A future perspective for a combined gastric cancer therapy?
- (2017) Christine Böger et al. OncoImmunology
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global patterns and trends in colorectal cancer incidence and mortality
- (2016) Melina Arnold et al. GUT
- A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
- (2016) Yi Li et al. International Journal of Biological Sciences
- Immunotherapy in human colorectal cancer: Challenges and prospective
- (2016) Xuan Sun et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Immunological Landscape and Clinical Management of Rectal Cancer
- (2016) Elísabeth Pérez-Ruiz et al. Frontiers in Immunology
- PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
- (2015) S. P. Patel et al. MOLECULAR CANCER THERAPEUTICS
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses
- (2015) Jun Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- VISTA Is an Immune Checkpoint Molecule for Human T Cells
- (2014) J. L. Lines et al. CANCER RESEARCH
- VISTA Regulates the Development of Protective Antitumor Immunity
- (2014) I. Le Mercier et al. CANCER RESEARCH
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Second-Line Chemotherapy Use in Metastatic Colon Cancer Varies by Disease Responsiveness
- (2008) Seth Politano et al. Clinical Colorectal Cancer
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started